Literature DB >> 7843128

Effects of organometals on cellular signaling. I. Influence of metabolic inhibitors on metal-induced arachidonic acid liberation.

A Käfer1, H F Krug.   

Abstract

Organic lead and tin compounds stimulate an increase of free arachidonic acid (AA) in HL-60 cells. This fatty acid is involved in numerous health problems and physiological mechanisms. Three major pathways result in a liberation of AA from membrane phospholipids and there is evidence that G-proteins serve as couplers within all three pathways. Therefore we investigated the influence of pertussis toxin (PT) on the organometallic-induced AA liberation. The effect of all studied compounds (organotin and organo-lead) was diminished by PT. We conclude that the organometals activate PLA2 to some extent via a PT-sensitive pathway. The ionophor A 23187 (1-10 microM) led to an increase of free AA by raising the intracellular Ca2+ level. One of the postulated ways of AA release is via Ca2+ channel activation; phospholipases are Ca2+ dependent. Thus, we examined the necessity of free intracellular Ca2+ for the organometallic effect. The Ca2+ chelator EGTA inhibited the increase of free AA induced by organometals. This is true also for verapamil, a Ca2+ channel blocker. Quinacrine, which is thought to be an inhibitor of phospholipase A2 (PLA2), prevented the AA liberation from membrane phospholipids induced by organometals. This could be due to the inhibition of PLA2, but it could also be the result of an inhibited Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843128      PMCID: PMC1567376          DOI: 10.1289/ehp.102-1567376

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  30 in total

Review 1.  Calcium-channel drugs: structure-function relationships and selectivity of action.

Authors:  D J Triggle
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

Review 2.  Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers.

Authors:  J Axelrod; R M Burch; C L Jelsema
Journal:  Trends Neurosci       Date:  1988-03       Impact factor: 13.837

Review 3.  Phospholipase A2: function and pharmacological regulation.

Authors:  J Chang; J H Musser; H McGregor
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

4.  Phospholipase A2 activation in chemotactic peptide-stimulated HL60 granulocytes: synergism between diacylglycerol and Ca2+ in a protein kinase C-independent mechanism.

Authors:  M M Billah; M I Siegel
Journal:  Biochem Biophys Res Commun       Date:  1987-04-29       Impact factor: 3.575

5.  Stimulation of arachidonic acid metabolism via phospholipase A2 by triethyl lead.

Authors:  H Krug; J Berndt
Journal:  Eur J Biochem       Date:  1987-01-15

6.  The stimulation of arachidonic acid metabolism by organic lead and tin compounds in human HL-60 leukemia cells.

Authors:  A Käfer; H Zöltzer; H F Krug
Journal:  Toxicol Appl Pharmacol       Date:  1992-09       Impact factor: 4.219

7.  Enhancement of eicosanoid synthesis in mouse peritoneal macrophages by the organic mercury compound thimerosal.

Authors:  V Kaever; M Goppelt-Strübe; K Resch
Journal:  Prostaglandins       Date:  1988-06

8.  Human platelet phospholipase A2 activity is responsive in vitro to pH and Ca2+ variations which parallel those occurring after platelet activation in vivo.

Authors:  B M Baron; L E Limbird
Journal:  Biochim Biophys Acta       Date:  1988-08-19

9.  Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2.

Authors:  R Bicknell; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation.

Authors:  R Testi; F M Pulcinelli; M G Cifone; D Botti; E Del Grosso; S Riondino; L Frati; P P Gazzaniga; A Santoni
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.